Cargando…
I-ACT for Children: helping close the gap in drug approval for adults and children
Autores principales: | Coppes, Max J., Jackson, Cindy, Connor, Edward M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589790/ https://www.ncbi.nlm.nih.gov/pubmed/36271160 http://dx.doi.org/10.1038/s41390-022-02349-5 |
Ejemplares similares
-
Research approvals iceberg: helping it melt away
por: Kolstoe, Simon E., et al.
Publicado: (2019) -
Time from US Food and Drug Administration approval to publication of data for cancer drugs: a comparison of first and subsequent approvals
por: Lammers, Austin, et al.
Publicado: (2017) -
Contemporary oncology trials, drug approvals and the physician-patient relationship
por: Schnog, John-John B., et al.
Publicado: (2022) -
Closing the yield gap: can metabolomics be of help?
por: Sulpice, Ronan
Publicado: (2020) -
Gap between pediatric and adult approvals of molecular targeted drugs
por: Nishiwaki, Satoshi, et al.
Publicado: (2020)